A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
Clinical trial NCT06695026 · RECRUITING
Trial details
- NCT number
- NCT06695026
- Sponsor
- Rznomics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2027-08-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.